3 November 2021
MaaT Pharma announces successful Initial Public Offering on the regulated market of Euronext Paris
MaaT Pharma S.A. ("MaaT Pharma" or the “Company“), a French clinical-stage biotech and a pioneer in the development of microbiome2-based ecosystem therapies dedicated to...